National Institute on Drug Abuse; Notice of Closed Meetings, 15595 [2024-04440]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 43 / Monday, March 4, 2024 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Stakeholder Listening Session for the
G20 Health Track
Office of Global Affairs,
Department of Health and Human
Services.
ACTION: Notice of public listening
session; request for comments.
AGENCY:
The listening session will be
held on Thursday, April 18, 2024, from
10 a.m. to 12 p.m. eastern daylight time.
This meeting is open to the public but
requires RSVP to oga.rsvp@hhs.gov by
April 12, 2024. See RSVP section in
SUPPLEMENTARY INFORMATION for details.
ADDRESSES: The session will be held
virtually, with online and dial-in
information shared with registered
participants.
DATES:
khammond on DSKJM1Z7X2PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Purpose: The U.S. Department of
Health and Human Services (HHS), with
support from relevant health-related
U.S. Government offices, is charged
with leading the U.S. engagement in the
Group of 20 (G20) Health Track and will
convene an informal Stakeholder
Listening Session.
The Stakeholder Listening Session is
designed to seek input from
stakeholders and subject matter experts
to help inform and prepare for U.S.
Government engagement with G20
health ministries.
The Group of Twenty (G20) is a major
forum for international economic
cooperation. It plays an important role
in defining and strengthening global
architecture and governance on major
international economic issues. Initially,
the G20 focused mainly on general
macroeconomic issues, but later
expanded its agenda to include topics
such as trade, sustainable development,
health, agriculture, energy, the
environment, climate change and the
fight against corruption.
The G20 is comprised of 19 countries
(Argentina, Australia, Brasil, Canada,
China, France, Germany, India,
Indonesia, Italy, Japan, Korea, Mexico,
Saudi Arabia, South Africa, Russia,
Tu¨rkiye, UK and USA) and two regional
bodies: the African Union and the
European Union. The members of the
G20 represent around 85% of the
world’s GDP, more than 75% of world
trade and around two-thirds of the
world’s population.
Each year, a different member country
holds the presidency of the group and
hosts the meetings. The presidency
VerDate Sep<11>2014
17:45 Mar 01, 2024
Jkt 262001
proposes the group’s priorities for the
year and hosts discussions to work
towards consensus positions and
actions on those priorities. This year’s
G20 presidency is Brazil, which will be
hosting Health Working Group meetings
throughout the year, culminating in a
Health Ministers’ Meeting on October
31, 2024, in Rio de Janeiro, Brazil.
Matters to be Discussed: The
Stakeholder Listening Session will
cover global health issues under the
general themes of global health security
and health systems strengthening that
could benefit from G20 engagement.
Participation is welcome from
stakeholder communities, including:
• Public health and advocacy groups
• State, local, and Tribal groups
• Private industry
• Minority health organizations
• Academic and scientific organizations
RSVP: Persons seeking to attend or
speak at the listening session must
register by Friday, April 12, 2024.
Registrants must include their full
name and organization, if any, and
indicate whether they are registering as
a listen-only attendee or as a speaker
participant to oga.rsvp@hhs.gov.
Requests to participate as a speaker
must include:
1. The name and email address of the
person desiring to participate
2. The organization(s) that person
represents, if any
3. Identification of the primary topic(s)
of interest
Other Information: Written comments
should be emailed to oga.rsvp@hhs.gov
with the subject line ‘‘Written Comment
Re: Stakeholder Listening Session in
preparation for the G20 Health Track’’
by Friday, April 25, 2024.
We look forward to your comments on
U.S. engagement in the G20 Health
Track.
Susan Kim,
Principal Deputy Assistant Secretary, Office
of Global Affairs.
[FR Doc. 2024–04473 Filed 3–1–24; 8:45 am]
BILLING CODE 4150–38–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
15595
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Reaching Equity at the Intersection of HIV
and Substance Use: Novel Approaches to
Address HIV Related Health Disparities in
Minority Populations.
Date: March 21, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Trinh T. Tran, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North
Stonestreet Avenue, MSC 6021, Bethesda,
MD 20892, (301) 827–5843, trinh.tran@
nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; REI:
Training and Diversifying the Data Science
Workforce for Addiction Research.
Date: May 22, 2024.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: February 27, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–04440 Filed 3–1–24; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\04MRN1.SGM
04MRN1
]]>Agencies
[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Page 15595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04440]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Reaching Equity at the Intersection of HIV and
Substance Use: Novel Approaches to Address HIV Related Health
Disparities in Minority Populations.
Date: March 21, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Trinh T. Tran, Ph.D., Scientific Review Officer,
Scientific Review Branch, Office of Extramural Policy, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 827-5843, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; REI: Training and Diversifying the Data Science
Workforce for Addiction Research.
Date: May 22, 2024.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 594-9460, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 27, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-04440 Filed 3-1-24; 8:45 am]
BILLING CODE 4140-01-P
